You could be part of a clinical study that helps regulatory authorities decide if a new combination therapy should be made available for people with type 2 diabetes.
You may qualify for this study if you:
- Are 18 years of age or older
- Have been diagnosed with Type II diabetes mellitus 180 days or more before screening